Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey

Anti-hepatitis C virus (HCV) antibody prevalence was investigated in 228 patients with lymphoproliferative disorders (LPDs). Twenty-six of 228 (11.40%) patients with LPDs were positive for anti-HCV which was higher than the donor population (P = 0.0007). Nine of 98 cases with non-Hodgkin's lymp...

Descripción completa

Detalles Bibliográficos
Autores principales: Paydas, S, Kiliç, B, Sahin, B, Buğdayci, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363073/
https://www.ncbi.nlm.nih.gov/pubmed/10424729
http://dx.doi.org/10.1038/sj.bjc.6690522
_version_ 1782153613186957312
author Paydas, S
Kiliç, B
Sahin, B
Buğdayci, R
author_facet Paydas, S
Kiliç, B
Sahin, B
Buğdayci, R
author_sort Paydas, S
collection PubMed
description Anti-hepatitis C virus (HCV) antibody prevalence was investigated in 228 patients with lymphoproliferative disorders (LPDs). Twenty-six of 228 (11.40%) patients with LPDs were positive for anti-HCV which was higher than the donor population (P = 0.0007). Nine of 98 cases with non-Hodgkin's lymphoma, five of 47 cases with multiple myeloma, seven of 36 cases with Hodgkin's disease, four of 38 cases with chronic lymphocytic leukaemia and one of nine cases with acute lymphoblastic leukaemia had anti-HCV antibody. In all patients, odds ratio (OR) for anti-HCV was 24.09. This value was higher in patients less than 35 years as 62.04 for below 25 years and 32.00 for between 25–35 years. Our findings suggest that HCV infection might be a causative and/or contributing factor in lymphoproliferation. © 1999 Cancer Research Campaign
format Text
id pubmed-2363073
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23630732009-09-10 Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey Paydas, S Kiliç, B Sahin, B Buğdayci, R Br J Cancer Regular Article Anti-hepatitis C virus (HCV) antibody prevalence was investigated in 228 patients with lymphoproliferative disorders (LPDs). Twenty-six of 228 (11.40%) patients with LPDs were positive for anti-HCV which was higher than the donor population (P = 0.0007). Nine of 98 cases with non-Hodgkin's lymphoma, five of 47 cases with multiple myeloma, seven of 36 cases with Hodgkin's disease, four of 38 cases with chronic lymphocytic leukaemia and one of nine cases with acute lymphoblastic leukaemia had anti-HCV antibody. In all patients, odds ratio (OR) for anti-HCV was 24.09. This value was higher in patients less than 35 years as 62.04 for below 25 years and 32.00 for between 25–35 years. Our findings suggest that HCV infection might be a causative and/or contributing factor in lymphoproliferation. © 1999 Cancer Research Campaign Nature Publishing Group 1999-07 /pmc/articles/PMC2363073/ /pubmed/10424729 http://dx.doi.org/10.1038/sj.bjc.6690522 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Paydas, S
Kiliç, B
Sahin, B
Buğdayci, R
Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey
title Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey
title_full Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey
title_fullStr Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey
title_full_unstemmed Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey
title_short Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey
title_sort prevalence of hepatitis c virus infection in patients with lymphoproliferative disorders in southern turkey
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363073/
https://www.ncbi.nlm.nih.gov/pubmed/10424729
http://dx.doi.org/10.1038/sj.bjc.6690522
work_keys_str_mv AT paydass prevalenceofhepatitiscvirusinfectioninpatientswithlymphoproliferativedisordersinsouthernturkey
AT kilicb prevalenceofhepatitiscvirusinfectioninpatientswithlymphoproliferativedisordersinsouthernturkey
AT sahinb prevalenceofhepatitiscvirusinfectioninpatientswithlymphoproliferativedisordersinsouthernturkey
AT bugdaycir prevalenceofhepatitiscvirusinfectioninpatientswithlymphoproliferativedisordersinsouthernturkey

Ejemplares similares